We identified allele *2 in the HS1.2 enhancer of the Igh 3' regulatory region (3'RR-1) as a risk factor for systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and systemic sclerosis (SSc) (scleroderma). An NF-κB binding site specific to allele *2 may contribute to the association of this allele with chronic inflammatory autoimmune diseases.
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The regulation of the humoral immune response depends upon cis-and trans-acting elements, among which is a 3' regulatory region of the immunoglobulin (Ig) heavy chain locus (2, 3) . Human Ig constant region genes are duplicated, with each segment followed by a 3' regulatory region (3'RR), (4) (supplementary Figure 1A) . Each 3'RR contains enhancer elements HS3, HS1.2 and HS4, which, as shown in mice, are involved in regulating B cell receptor expression, Ig germline transcription and class switching (3) . While HS3 and HS4 enhancers in 3' RR-1 are identical to those in 3'RR-2, the HS1.2 enhancer is polymorphic, with variable numbers of tandem repeats and spacers, accompanied by predicted differences in transcription factor binding sites (5, 6) . In this study, we report the frequencies of the four alleles of HS1.2 of 3'RR-1 in three cohorts of patients [158 with SLE, 233 with RA (7) , and 135 with SSC (8)] compared to those obtained in 573 control subjects of the general population of the same area ( Table 1 ). HS1.2 allele frequency in each of the three cohorts (total=526) is very similar (<3% variation, Sup Table1, Sup Figure2). 3'RR-1 HS1.2 alleles *1 and *2 are the most prevalent, while HS1.2 alleles *3 and *4 are poorly represented in patients and general populations with no significant changes. Notably, in each patient cohort, allele *2 homozygousity is almost double that of the controls. These data suggest that HS1.2 allele *2 is associated with these chronic inflammatory autoimmune diseases (Table 1, suppl. Fig2 ). Compared to 3' RR-1, only modest changes in 3' RR-2 allele frequency were detected, therefore neglected in this study.
Sequence differences in 3' RR-1 HS1.2 alleles*1 and *2 are associated with predicted differences in transcription factor binding sites (5) . Electrophoretic mobility shift assays (EMSA) have been used to locate binding sites for transcription factors SP1 and NF-κB in HS1,2 alleles (9). Additional EMSA with allele *1 or *2 as probes was carried out with nuclear protein extracts derived from the human pro-B cell line FLEB14 ( Figure 1 ). Only one band, a, was detected with allele *1 while three bands, a, b, and c were detected with allele *2. Using segments of allele *2 as potential competitors, or specific antibodies against transcription factors for supershift analysis, we found that the single band of allele *1 (a) is (5) . These latter alleles bear at high (> 95%) frequency, a 29 bp element that replaces the SP1-binding 18 bp element at the 5' end of the polymorphic region. This 29 bp element is predicted to contain a USF site that could endow the 3'RR-2 with an insulator role (5) . The binding of HS1.2 and HS4 enhancers to nuclear protein complexes, including NF-κB, was previously demonstrated (10, 11) . We, therefore, anticipate that specific haplotypes linked to the HS1.2 enhancer could drive the risk for the diseases. In fact, in the 4 kb segment where HS1.2 is embedded, fewer haplotypes are linked to allele *2 than to allele *1 (results not shown). This suggests an instability of allele *2 in the presence of changes in the surrounding region, probably due to conformations, mobility after epigenetic changes when bound to protein factors.
This study shows a significant increase in the frequency of allele *2 compared to allele *1 of the HS1.2 enhancer downstream of Cα1 of the Ig heavy chain locus in patients with three systemic autoimmune diseases. A similar association of HS1.2 allele *2 with celiac disease (12) and psoriasis (13) was also observed, thus reinforcing its relationship with autoimmunity. Recent observations revealed HS1.2 polymorphism related to IgA deficiency (14) and to relative levels of Igh expression (9) . EMSA indicates that NFκB binds uniquely to a central region of allele *2, which is absent from allele *1. NF-kB is a pivotal factor in B cell maturation, involved either in innate as well as in adaptive immunity (15) . On these basis we predict that HS1.2 allele *2, can bias toward a pathological immune response in conjunction with other factors that interact with HS1.2 enhancer binding complexes. It will be important to determine the influence, at the epigenetic level, of haplotypes of the Igh 3'
RRs in the immune response. 
EMSA experiments
Electrophoretic mobility shift assay (EMSA)
Nuclear extract preparation and EMSA were performed as described (9);
The sequences for the probes were : allele *1 (227 bp) accession number AJ544218. 
